By Anna Azvolinsky, PhD | May 18, 2011
Roland B. Walter and his colleagues at the Fred Hutchinson Cancer Research Center and the University of Washington analyzed a total of 64,839 men and women between the age of 50 and 76 years. These patients were recruited over a two-year span from 2000 to 2002 for the Vitamins and Lifestyle (VITAL) study. All analyses were adjusted for age, sex, race, education, smoking, arthritis, migraines, headaches, and family history of hematologic malignancies such as leukemia and lymphoma, among others.
The results of the analysis showed an increased risk of hematologic malignancies incidence associated with high use (more than 4 days a week for more than 4 years) of acetaminophen (hazard ration = 1.84, P =0.004). The association was seen for myeloid neoplasms, non-Hodgkin’s lymphomas, and plasma cell disorders. There was no association of high acetaminophen use with CLL/SLL.
The study did not find an association of hematologic malignancy risk with aspirin, ibuprofen(Drug information on ibuprofen), or nonaspirin NSAIDs.